IT Management, ERP, M and A integration and Business Transformation Consultant @ Striatum Technology Consultants (April 2018 - Present)
Vice President Information Technology @ Karuna Therapeutics - acquired by Bristol Myers Squibb (July 2023 - May 2025)
Vice President Information Technology @ Albireo Pharma, Inc. - acquired by IPSEN BIOSCIENCE (December 2022 - June 2023)
Vice President Information Technology @ (October 2021 - December 2022)
Vice President Information Technology @ Epizyme - acquired by IPSEN BIOSCIENCE (March 2019 - October 2021)
Head of Enterprise Management and Technology Transfer (CIO equivalent) @ (January 2008 - April 2018)
Sr. Director, Global Program Management and Business Optimization @ (January 2008 - January 2018)
AVP, International Operations and Business Development @ (January 2008 - January 2018)
Owner and Principal Business Application and SAP Consultant @ Strategic Alliance Group, Inc (January 1998 - December 2008)
International Sr. Business System Analysts and MIS Manager and SW dev @ (January 1992 - January 1998)
Design and Software Engineer @ (January 1988 - January 1992)
Michael Catarina Education
Bryant University
MBA (International Business)
University of Rhode Island
BS (Computer Electrical Engineering)
Michael Catarina Skills
Biotechnology
Business Analysis
Business Development
Business Strategy
Change Management
Consulting
Cross-functional Team Leadership
ERP
Enterprise Software
Executive Management
FDA
IT Management
IT Strategy
Integration
Leadership
Life Sciences
M&A experience
Management
Medical Devices
Mergers & Acquisitions
Microsoft Dynamics
Oracle
Pharmaceutical Industry
Process Improvement
Product Launch
Program Management
Project Management
SAP
SAP ERP
Solution Architecture
Strategic Planning
Strategy
Team Leadership
Vendor Management
Michael Catarina Summary
Michael Catarina, based in Cambridge, MA, US, is currently a Chief Technology Officer at Organogenesis. Michael Catarina brings experience from previous roles at Striatum Technology Consultants, Karuna Therapeutics - acquired by Bristol Myers Squibb, Albireo Pharma, Inc. - acquired by IPSEN BIOSCIENCE and Repertoire Immune Medicines. Michael Catarina holds a MBA in International Business @ Bryant University. With a robust skill set that includes Biotechnology, Business Analysis, Business Development, Business Strategy, Change Management and more. Michael Catarina has 2 emails and 1 mobile phone numbers on RocketReach.
Looking for a different Michael Catarina?
Find contact details for 700 million professionals.